Orexin Receptor Antagonists Market Trends, Drivers, and Restraints: Analysis and Forecast by 2030

Data Bridge Market Research analyses a growth rate in the global orexin receptor antagonists market in the forecast period 2022-2029.

"The reliable  orexin receptor antagonists Market research report offers a thorough understanding of the current scenario in the global market, recent developments, product launches, joint ventures, capacity, production value, mergers, and acquisitions based on numerous market dynamics. This report is crafted with the requirements of businesses in mind, essential for achieving successful business growth. Company profiles of the main market competitors are analyzed in this report, considering company snapshot, geographical presence, product portfolio, and recent developments. The orexin receptor antagonists Market research study also helps identify types of consumers, their perspectives on the product, their buying intentions, and their ideas for product improvement.

Moreover, the orexin receptor antagonists Market survey report is promising and forward-looking. A team of researchers, forecasters, analysts, and industry experts carefully formulate this market research report by thinking from the customer's perspective. The studies, insights, and analysis in this market report provide a clear idea about the marketplace, making business decisions easy and quick. An excellent orexin receptor antagonists Market analysis report is one of the most relevant, special, reasonable, and admirable market research reports crafted to meet business needs.

Data Bridge Market Research analyses a growth rate in the global orexin receptor antagonists market in the forecast period 2022-2029.

Explore Further Details about This Research orexin receptor antagonists Market Report https://www.databridgemarketresearch.com/reports/global-orexin-receptor-antagonists-market

Orexin Receptor Antagonists Market Scope and Segmentation



Forecast Period

2022 to 2029

Base Year


Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Dosage (5mg, 10mg, 15mg, and 20mg), Drugs (Suvorexant, Lemborexant, Others), Application (insomnia, Depression, Anxiety, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Eisai Co., Ltd (Japan), Sun Pharmaceutical Industries Ltd. (India), Novartis AG (Switzerland), Endo Pharmaceuticals plc (Ireland), Mylan N.V. (U.S.), Mayne Pharma Group Limited (Australia), Teva Pharmaceutical Industries Ltd (Israel), Amneal Pharmaceutical Inc (U.S.), Mayne Pharma Group Limited (Australia), Merck KGaA (Germany), Sanofi (France), Currax Pharmaceuticals LLC (India)

Market Opportunities

  • Increasing Cases of Insomnia

Market Definition

Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders,  characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.          

Global Orexin Receptor Antagonists Market Dynamics


  • Increased Clinical Research

There has been advanced clinical research that is boosting the growth of the market. For instance, daridorexant showed good safety and tolerance profile in OSA patients.In a 2020 randomized, placebo-controlled study, no clinically or statistically significant differences were found in AHI between daridorexant and placebo. Thus, it boosts the market growth.

  • Technological Development

Increased technological developments in the pharmaceutical sector to manufacture advanced tricyclic antidepressant drugs is anticipated to boost remunerative opportunities for the expansion of the global orexin receptor antagonists market during the forecast period 2022-2029. Additionally, the presence of key manufacturing companies to develop antidepressant drugs boost growth of the market.


  • Increasing Cases of Insomnia

Insomnia is the major contributor to the market in 2020, and is projected to remain dominant during the forecast period, mainly due to the rise in healthcare awareness, increase in the occurrence of sleep apnea, reduction in physical exercise by the population and growth in the geriatric population. As per the records of the American Academy of Sleep Medicine AASM) in 2014,  insomnia affects 30% of adults, 15-20% have short-term insomnia and 10% of adults have chronic insomnia worldwide. All these factors contributes to create opportunity to the market.

Key Coverage in the  orexin receptor antagonists Market Report:

  • Detailed analysis of Global orexin receptor antagonists Market by a thorough assessment of the technology, product type, application, and other key segments of the report
  • Qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period
  • Investigative study of the market dynamics including drivers, opportunities, restraints, and limitations that can influence the market growth
  • Comprehensive analysis of the regions of the orexin receptor antagonists Market and their futuristic growth outlook
  • Competitive landscape benchmarking with key coverage of company profiles, product portfolio, and business expansion strategies

Browse Related Reports:

Pediatric Interventional Cardiology Market to Perceive Prominent Growth of Billion by Size, Share, Trends, Demand, Growth and Competitive Analysis


Ion Chromatography Mass Spectrometry Market Forecasted to Exhibit an Incredible Growth of Billion by Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis


Aesthetic and Cosmetic Surgery Devices Market Anticipated to Garner Significant Growth of Billion By Size, Share, Trends, Opportunities, Key Drivers, and Revenue Forecast


Colorectal Surgical Devices Market Poised to Achieve Exponential CAGR Growth by Size, Share, Trends, Opportunities, Key Drivers, and Revenue Forecast


Internal Neurostimulation Devices Market to Notice Prominent CAGR Growth by Size, Share, Trends, Demand, Growth and Competitive Outlook


Optical Preclinical Imaging Market to Observe Utmost Growth of Billion by Size, Share, Trends, Demand, Key Players and Growth Factors


Immunofluorescence Market is Probable to Influence the Value of Billion by Size, Share, Trends, Growth and Competitive Outlook


Blood Screening Market is Likely to Upsurge at Billion Globally by  Size, Share, Trends, Demand, Growth and Opportunity Analysis


Cardiopulmonary Bypass Accessory Equipment Market To Perceive Highest Growth of Billion by Size, Share, Trends, Key Growth Drivers and Opportunity Analysis


Assistive Technology in Down Syndrome Market to Receive Billion by Size, Shares, Trends, Demand, Growth Opportunities and Revenue Analysis


About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]


vaibhav thorbole

232 Blog posts